X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1696) 1696
Publication (146) 146
Book Review (13) 13
Book Chapter (11) 11
Dissertation (6) 6
Conference Proceeding (5) 5
Book / eBook (3) 3
Paper (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1163) 1163
paraoxonase (838) 838
index medicus (808) 808
male (796) 796
female (785) 785
middle aged (579) 579
oxidative stress (555) 555
aryldialkylphosphatase - genetics (537) 537
adult (465) 465
polymorphism (418) 418
atherosclerosis (411) 411
aged (352) 352
serum paraoxonase (345) 345
paraoxonase 1 (343) 343
genotype (342) 342
aryldialkylphosphatase - metabolism (333) 333
low-density-lipoprotein (333) 333
aryldialkylphosphatase - blood (322) 322
enzymes (320) 320
risk factors (308) 308
polymorphism, genetic (306) 306
arylesterase (290) 290
pon1 (277) 277
animals (265) 265
risk (256) 256
biochemistry & molecular biology (254) 254
antioxidants (220) 220
case-control studies (215) 215
genetic aspects (212) 212
aryldialkylphosphatase (207) 207
toxicology (189) 189
association (188) 188
high-density-lipoprotein (178) 178
pharmacology & pharmacy (175) 175
polymorphisms (174) 174
cholesterol (162) 162
lipoproteins (161) 161
disease (160) 160
analysis (159) 159
coronary-heart-disease (155) 155
heart-disease (155) 155
molecular-basis (155) 155
cardiovascular-disease (154) 154
alleles (151) 151
lipids (151) 151
human serum paraoxonase (141) 141
myocardial-infarction (141) 141
coronary-artery-disease (138) 138
gene frequency (136) 136
cardiovascular disease (129) 129
medicine, research & experimental (129) 129
research (128) 128
oxidation (127) 127
physiological aspects (126) 126
esterases - genetics (125) 125
lipid-peroxidation (124) 124
genetic predisposition to disease (123) 123
mice (117) 117
peripheral vascular disease (115) 115
plasma (115) 115
hdl (114) 114
genetic polymorphisms (112) 112
polymorphism, single nucleotide (111) 111
gene polymorphisms (110) 110
gene (107) 107
inflammation (106) 106
diabetes (105) 105
coronary heart disease (104) 104
endocrinology & metabolism (104) 104
gene polymorphism (104) 104
expression (102) 102
adolescent (100) 100
low density lipoproteins (100) 100
cell biology (98) 98
genetics & heredity (98) 98
genes (97) 97
pesticides (97) 97
genetics (96) 96
medical laboratory technology (95) 95
phenotype (95) 95
population (95) 95
young adult (95) 95
carboxylic ester hydrolases - blood (94) 94
polymerase chain reaction (93) 93
biomarkers - blood (92) 92
aged, 80 and over (90) 90
health aspects (90) 90
neurosciences (89) 89
lipid peroxidation (87) 87
metabolism (86) 86
lipids - blood (84) 84
paraoxonase activity (84) 84
serum (84) 84
toxicity (83) 83
coronary artery disease (82) 82
cardiac & cardiovascular systems (81) 81
environmental sciences (79) 79
medicine (79) 79
paraoxonase-1 (78) 78
genetic research (77) 77
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1684) 1684
Spanish (11) 11
Japanese (10) 10
Turkish (5) 5
Polish (3) 3
Russian (3) 3
Catalan (2) 2
German (2) 2
Portuguese (2) 2
Chinese (1) 1
Czech (1) 1
French (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Life Sciences, ISSN 0024-3205, 09/2019, Volume 232, p. 116646
Some previous studies already explored associations between paraoxonase 1 ( ) polymorphisms and atherosclerotic cardiovascular diseases (ASCVD), with... 
Paraoxonase 1 (PON1) | Polymorphisms | Atherosclerotic cardiovascular diseases (ASCVD) | Meta-analysis | MEDICINE, RESEARCH & EXPERIMENTAL | OXIDATIVE STRESS | PHARMACOLOGY & PHARMACY | LOCI | GENE POLYMORPHISMS | ISCHEMIC-STROKE | EPIDEMIOLOGY
Journal Article
Free Radical Research, ISSN 1071-5762, 12/2019, Volume 53, Issue 11-12, pp. 1045 - 1050
Some previous studies already explored associations between paraoxonase 1 (PON1) polymorphisms and cancer, with conflicting findings. Here, we aimed to better... 
paraoxonase 1 (PON1) | meta-analysis | polymorphisms | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, pp. e0133719 - e0133719
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 5, p. e17805
Background: Human serum paraoxonase-1 (PON1) prevents oxidation of low density lipoprotein cholesterol (LDL-C) and hydrolyzes the oxidized form, therefore... 
DEPENDENT DIABETES-MELLITUS | PESTICIDE EXPOSURE | PROMOTER POLYMORPHISMS | GENETIC-POLYMORPHISM | MULTIDISCIPLINARY SCIENCES | ATHEROSCLEROSIS | HUMAN-SERUM PARAOXONASE | CORONARY-HEART-DISEASE | VASCULAR-DISEASE | ARTERY-DISEASE | GLN-ARG192 POLYMORPHISM | Genetic Testing | Humans | Middle Aged | Risk Factors | Genotype | Male | Phenylacetates - metabolism | Coronary Artery Disease - enzymology | Aryldialkylphosphatase - genetics | Aryldialkylphosphatase - metabolism | India | Haplotypes - genetics | Paraoxon - metabolism | Coronary Artery Disease - genetics | Polymerase Chain Reaction | Adult | Female | Polymorphism, Genetic - genetics | Medical research | Low density lipoproteins | Genes | Atherosclerosis | Medicine, Experimental | Genetic aspects | Coronary heart disease | Risk factors | Cholesterol | Genetic polymorphisms | Haplotypes | Lipoproteins (low density) | Arylesterase | Paraoxonase 1 | Stenosis | Cardiovascular disease | Alcohol | Biochemistry | Gene polymorphism | Regression models | Population | Oxidation | Heart diseases | Genotypes | Internal medicine | Paraoxon | Coronary artery | Health risks | Paraoxonase | Risk analysis | Health education | Coronary artery disease | Patients | Low density lipoprotein | Minority & ethnic groups | Substrates | Polymerase chain reaction | Studies | Restriction fragment length polymorphism | Genotyping | Arteriosclerosis | Coronary vessels | Diabetes | Binding sites | Polymorphism
Journal Article
Clinical Rheumatology, ISSN 0770-3198, 8/2019, Volume 38, Issue 8, pp. 2141 - 2149
We reviewed the associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis (RA) patients and compared... 
Activity | Medicine & Public Health | Rheumatoid arthritis | Rheumatology | PON1 | Polymorphism | ANTIBODIES | ANTIOXIDANTS | DISEASE | RISK | RHEUMATOLOGY | GENE POLYMORPHISM | Rheumatoid factor | Medical colleges | Medical research | Medicine, Experimental | Arthritis | Genetic aspects | Comparative analysis | Genetic polymorphisms | Paraoxonase 1 | Alleles | Paraoxonase | Gene polymorphism | Meta-analysis
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 60, pp. 101095 - 101102
Esophagogastric junction adenocarcinoma (EGJA) is a serious public health problem with high mortality in China. In this study, we assessed the association... 
Esophagogastric junction adenocarcinoma | PON1 | Polymorphism | OXIDATIVE STRESS | DIETARY HABITS | esophagogastric junction adenocarcinoma | polymorphism | TRENDS | GASTRIC CARDIA | BREAST | DAMAGE | CELL BIOLOGY | LUNG-CANCER | SERUM PARAOXONASE | DISEASE | CANCER-RISK
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, p. e110188
Clopidogrel is an antiplatelet prodrug that is recommended to reduce the risk of recurrent thrombosis in coronary artery disease (CAD) patients. Paraoxonase 1... 
HEART-DISEASE | STENT THROMBOSIS | OF-FUNCTION POLYMORPHISM | Q192R POLYMORPHISM | MULTIDISCIPLINARY SCIENCES | DENSITY-LIPOPROTEIN | MAJOR DETERMINANT | ACUTE MYOCARDIAL-INFARCTION | GENE POLYMORPHISMS | PLATELET REACTIVITY | CLINICAL-OUTCOMES | Ticlopidine - pharmacology | Ticlopidine - therapeutic use | Humans | Middle Aged | Cytochrome P-450 CYP2C19 - genetics | Genotype | Male | Coronary Artery Disease - enzymology | Coronary Artery Disease - drug therapy | Aryldialkylphosphatase - genetics | Ticlopidine - analogs & derivatives | Adenosine Diphosphate - pharmacology | Polymorphism, Genetic | Coronary Artery Disease - physiopathology | Coronary Artery Disease - genetics | Aged, 80 and over | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Aged | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - therapeutic use | Care and treatment | Analysis | Cytochrome P-450 | Genetic aspects | Coronary heart disease | Thrombosis | Genetic polymorphisms | Blood clot | Cytochrome | Heart attacks | Linkage disequilibrium | Paraoxonase 1 | Cardiovascular disease | Agglomeration | Epistasis | Biochemistry | Family medical history | ADP | Risk factors | Clinical outcomes | Blood platelets | Oxidation | Thromboembolism | Heart diseases | Stents | Genotypes | Medical research | Enzymes | Aspirin | Diabetes mellitus | Cytochrome P450 | Coronary artery | Risk reduction | Whites | Platelet aggregation | Paraoxonase | Risk analysis | Coronary artery disease | Patients | Medicine | Studies | Hospitals | Coronary vessels | Alleles | Clopidogrel | Smoking
Journal Article
Journal of Diabetes and Its Complications, ISSN 1056-8727, 2006, Volume 20, Issue 5, pp. 322 - 328
Journal Article
Journal Article
Journal Article